| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/26/2009 | WO2009025478A1 Indole and indazole compounds as an inhibitor of cellular necrosis |
| 02/26/2009 | WO2009025477A1 Indole compounds as an inhibitor of cellular necrosis |
| 02/26/2009 | WO2009025265A1 Piperazine derivative |
| 02/26/2009 | WO2009025159A1 Detection and treatment of schizophrenia |
| 02/26/2009 | WO2009025091A1 Pharmaceutical composition for treatment of fibromyalgia |
| 02/26/2009 | WO2009024998A1 Nitric oxide releasing derivatives of paracetamol |
| 02/26/2009 | WO2009024980A2 Pyrimidine and pyridine derivatives as posh and posh-ap inhibitors |
| 02/26/2009 | WO2009024906A1 4-pyrimidinesulfamide derivative |
| 02/26/2009 | WO2009024615A1 Aminobenzyl-substituted cyclic sulfones useful as bace inhibitors |
| 02/26/2009 | WO2009024611A2 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use |
| 02/26/2009 | WO2009024543A1 Use of tranilast and derivatives thereof for the therapy of neurological conditions |
| 02/26/2009 | WO2009024517A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl heteroaryl derivatives useful as nicotinic acetylcholine receptor ligands |
| 02/26/2009 | WO2009024516A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as nicotinic acetylcholine receptor ligands |
| 02/26/2009 | WO2009024515A1 1,4-diaza-bicycl0(3.2.2)n0nyl pyrimidinyl derivatives useful as nicotinic acetylcholine- receptor ligands |
| 02/26/2009 | WO2009024502A1 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/26/2009 | WO2009024325A2 Treatment of sleep disorders |
| 02/26/2009 | WO2009023903A1 Compositions comprising phospholipids |
| 02/26/2009 | WO2009001046A3 [11c]methoxy-radiolabelled 2,3',4,5'-tetramethylstilbene (tms) and its preparation and use |
| 02/26/2009 | WO2008151803A3 New polymorphisms in abcb1 associated with a lack of clinical response to medicaments |
| 02/26/2009 | WO2008125337A3 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals |
| 02/26/2009 | WO2008109724A3 Treatment of cocaine-induced fetal brain injury |
| 02/26/2009 | WO2008094222A3 Porphyrin catalysts and methods of use thereof |
| 02/26/2009 | WO2008090585A3 Soluble forms of inclusion complexes of histone deacetylase inhibitors and cyclodextrins, their preparation processes and uses in the pharmaceutical field |
| 02/26/2009 | WO2008030579A3 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 02/26/2009 | US20090055941 Novel Neural Cell Specific Promoter And Baculovirus And Method For Gene Delivery |
| 02/26/2009 | US20090054523 Use of a Fatty Acid Composition Containing DHA for the Production of a Medical Product or a Food Stuff for the Treatment of Amyloidos-Related Diseases |
| 02/26/2009 | US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis |
| 02/26/2009 | US20090054489 Multimediator Dopamine Transport Inhibitors, and Uses Related Thereto |
| 02/26/2009 | US20090054484 Substituted heteroaryl benzofuran acids |
| 02/26/2009 | US20090054480 Novel quinuclidine carbamate derivatives and medicinal compositions containing the same |
| 02/26/2009 | US20090054472 Pyrazolopyrimidine Derivatives or Pharmaceutically Acceptable Salts Thereof |
| 02/26/2009 | US20090054468 New Use 938 |
| 02/26/2009 | US20090054462 Hydroisoindoline tachykinin receptor antagonists |
| 02/26/2009 | US20090054459 Substituted indoles |
| 02/26/2009 | US20090054454 Benzofuranyl- and benzothienyl- piperazinyl quinolines and methods of their use |
| 02/26/2009 | US20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 02/26/2009 | US20090054446 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists |
| 02/26/2009 | US20090054445 Amide Substituted Quinolines |
| 02/26/2009 | US20090054443 Compositions containing riboflavin and sesamin-class compounds |
| 02/26/2009 | US20090054440 Quinoline derivatives as neurokinin receptor antagonists |
| 02/26/2009 | US20090054437 Nitrocatechol Derivatives as Comt Inhibitors |
| 02/26/2009 | US20090054433 Pharmaceutical compositions containing quinazoline derivatives for treating as serotonin receptor antagonist |
| 02/26/2009 | US20090054431 Novel heterocycle compounds |
| 02/26/2009 | US20090054429 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| 02/26/2009 | US20090054427 Aminobenzyl-substituted cyclic sulfones useful as bace inhibitors |
| 02/26/2009 | US20090054426 Treatment of central nervous system disorders |
| 02/26/2009 | US20090054420 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/26/2009 | US20090054416 1,4-Diazabicyclo[3.2.2]nonanecarboxamide Derivatives, Preparation and Therapeutic Use Thereof |
| 02/26/2009 | US20090054412 Treatment of Sleep Disorders |
| 02/26/2009 | US20090054410 Thiadiazole derivatives for the treatment of neurodegenerative diseases |
| 02/26/2009 | US20090054408 2-(2-Oxo-3-pyridin-2-ylimidazolidin-1-yl)-N-(2'-oxo-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)acetamide; CGRP (Calcitonin Gene-Related Peptide); headache, migraine or cluster headache |
| 02/26/2009 | US20090054404 Use of r-10-hydroxy-10,11-dihydro-carbamazepine in neuropathic pain |
| 02/26/2009 | US20090054397 Pyrazole compounds and pharmaceutical compositions comprising the compound |
| 02/26/2009 | US20090054392 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | US20090054385 Solid inhalation formulations of dehydroepiandrosterone derivatives |
| 02/26/2009 | US20090054377 Compositions and methods for smoking cessation |
| 02/26/2009 | US20090054353 Mannosyl-1 phosphates, preparation method and therapeutic use, in particular against the cdg-ia syndrome |
| 02/26/2009 | US20090054351 Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases |
| 02/26/2009 | US20090054327 Human immunodeficiency virus transactivator protein (HIV-TAT)-utrophin fusion for use in treatment of muscular disorders |
| 02/26/2009 | US20090054325 Compositions and methods for suppressing axonal growth inhibition |
| 02/26/2009 | US20090054321 Polypeptides and use thereof |
| 02/26/2009 | US20090054307 Prophylactic and therapeutic agents and uses therefor |
| 02/26/2009 | US20090054302 Methods and Preparations For Curing Clinically Ill Patients |
| 02/26/2009 | US20090053805 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 02/26/2009 | US20090053802 Multipotent stem cells from peripheral tissues and uses thereof |
| 02/26/2009 | US20090053342 Preparation of microbial oil |
| 02/26/2009 | US20090053334 Ghrelin production promoter |
| 02/26/2009 | US20090053329 Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics |
| 02/26/2009 | US20090053219 Methods and compositions for increasing alpha-l-iduronidase activity in the cns |
| 02/26/2009 | US20090053214 Antibodies to myelin associated glycoprotein (MAG); neurological diseases/disorders |
| 02/26/2009 | US20090053143 Liquid inhalation formulations of dehydroepiandrosterone derivatives |
| 02/26/2009 | DE202008000656U1 Zusammensetzung zur Behandlung von nervösen Fehlfunktionen, Unruhezuständen und Schlafstörungen Composition for the treatment of nervous dysfunction, restlessness and sleep disturbances |
| 02/26/2009 | DE112007001030T5 Amyloid-ß-Fibrillogenese-inhibierendes Peptid Amyloid-beta fibrillogenesis-inhibiting peptide |
| 02/26/2009 | CA2734710A1 Pyrimidine and pyridine derivatives as posh and posh-ap inhibitors |
| 02/26/2009 | CA2698205A1 New use 938 |
| 02/26/2009 | CA2697325A1 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/26/2009 | CA2697254A1 Aminobenzyl-substituted cyclic sulfones useful as bace inhibitors |
| 02/26/2009 | CA2697100A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | CA2696693A1 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |
| 02/26/2009 | CA2696680A1 1,4-diaza-bicycl0(3.2.2)n0nyl pyrimidinyl derivatives useful as nicotinic acetylcholine- receptor ligands |
| 02/26/2009 | CA2696631A1 Heterocycles as potassium channel modulators |
| 02/26/2009 | CA2696627A1 Psma binding ligand-linker conjugates and methods for using |
| 02/26/2009 | CA2696582A1 Use of tranilast and derivatives thereof for the therapy of neurological conditions |
| 02/26/2009 | CA2695511A1 4-pyrimidinesulfamide derivative |
| 02/26/2009 | CA2691450A1 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 02/25/2009 | EP2028274A2 An antisense oligonucleotide against the TGF-beta2 gene |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP2028180A1 Novel aminopyridine derivatives as mGluR5 antagonists |
| 02/25/2009 | EP2027889A1 New neuronal viability factor and use thereof |
| 02/25/2009 | EP2027872A1 Neurotoxic component of a botulinum toxin for treating a facial disease |
| 02/25/2009 | EP2027868A1 Use of SCO-Spondin peptides for inhibiting or preventing neuronal apoptosis mediated by cell death receptor ligands |
| 02/25/2009 | EP2027866A1 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 02/25/2009 | EP2027861A1 Use of 3,11b-cis-dihydrotetrabenazine for the treatment of symptoms of Huntington's didease |
| 02/25/2009 | EP2027856A1 Method of treating or preventing central nervous system disorders with compounds having selectivity benzodiazepine receptor |
| 02/25/2009 | EP2027853A2 Kinase inhibitors for treating cancers |
| 02/25/2009 | EP2027851A1 Topical pharmaceutical formulations and methods of treatment |
| 02/25/2009 | EP2027129A2 Fused heterocylic compounds and their use as mglur5 modulators |
| 02/25/2009 | EP2027128A2 Fused heterocylic compounds and their use as mglur5 modulators |
| 02/25/2009 | EP2027122A1 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use |
| 02/25/2009 | EP2027120A2 Mglur5 modulators i |